Conference abstract · 29 May 2017
Conference abstractPublished 31 Jul 2017
Novel Staphylococcal phage endolysin, SAL-1
NtRON Biotechnology, Korea
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: A wide variety of bacteria can cause severe infections. Many of these bacteria are or have become resistant to many commonly used antibiotics. Infections due to drug-resistant bacteria require treatment with new types of antibiotics. Phage endolysins differ from standard-of-care antibiotics with regard to their potency, speed, specificity, and activity against antibiotic-resistant strains. Therefore, phage endolysins represent a promising research target for the discovery and development of novel antibacterial therapeutic agents. Materials & Method: We developed phage endolysin SAL-1 using genetic information of staphylococcal bacteriophage SAP-1. For current and future clinical studies of SAL-1, we performed the development of its efficient production process and ELISA assay method, preformulation study and its characterization. Findings: We established an efficient soluble production process for SAL-1 and ELISA assay method to be used in pharmacokinetic study. In addition, various characteristic of SAL-1 including pI, antibacterial activity were identified. Furthermore, appropriate formulation providing acceptable storage- and handling-stability was developed. Conclusion: Essential prerequisite technologies for conducting clinical studies for SAL-1-containing drug candidate were developed. We anticipate that this presentation will provide incentives for developing phage endolysin-based antibacterial agents to combat other bacterial infections.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 25 Jul 2020
Antibacterial properties of three newly identified recombinant Staphylococcus aureus phage endolysins
Short communication · 2019
Antibiotics 2019: Antibacterial properties of three newly identified recombinant Staphylococcus aureus phage endolysins
Research article · 26 Feb 2019
Fersis-Phage against Purulent-Inflammatory (Staphylococcal, Streptococcal) Pathologies
Research article · 2018
Evaluation for the Novel mecC Methicillin Resistance among Methicillin Resistant Staphylococcal Isolates in two Egyptian University Hospitals
More from this journal
The newest in Journal of Drug Metabolism & Toxicology.
Short communication · 30 Dec 2025
Liver Drug Metabolism Mechanisms Challenges and Future Perspectives
Opinion · 30 Dec 2025
Hepatic metabolism forms the foundation of drug disposition in the human body
Opinion · 30 Dec 2025
Biomarkers of Toxicity for Monitoring Adverse Drug Reactions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Drug Metabolism & Toxicology
- SubjectDiabetes & Endocrinology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Gi-Mo Jung”
- BylineArticles whose byline prints “Kim J W”
- BylineArticles whose byline prints “Jun S Y”
- BylineArticles whose byline prints “Yoon S J”
- BylineArticles whose byline prints “Kang S H”
- BylineArticles whose byline prints “Myung-Soo Kang”

